Home/Filings/4/0001225208-12-022233
4//SEC Filing

Reininger Cornelia 4

Accession 0001225208-12-022233

CIK 0000810509other

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 2:12 PM ET

Size

5.1 KB

Accession

0001225208-12-022233

Insider Transaction Report

Form 4
Period: 2012-11-01
Reininger Cornelia
SVP & Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-11-01+88,00088,000 total
    Exercise: $2.85Exp: 2022-11-01Common Stock (88,000 underlying)
Footnotes (1)
  • [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.

Documents

1 file

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001559878

Filing Metadata

Form type
4
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 2:12 PM ET
Size
5.1 KB